Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Share-based Compensation (2024 - 2025)

Historic Share-based Compensation for Kestra Medical Technologies (KMTS) over the last 2 years, with Q4 2025 value amounting to $8.7 million.

  • Kestra Medical Technologies' Share-based Compensation rose 67121.21% to $8.7 million in Q4 2025 from the same period last year, while for Oct 2025 it was $36.0 million, marking a year-over-year increase of 149309.73%. This contributed to the annual value of $24.3 million for FY2025, which is 153111.56% up from last year.
  • Kestra Medical Technologies' Share-based Compensation amounted to $8.7 million in Q4 2025, which was up 67121.21% from $4.6 million recorded in Q3 2025.
  • Kestra Medical Technologies' 5-year Share-based Compensation high stood at $22.3 million for Q2 2025, and its period low was $372000.0 during Q1 2024.